Publicly traded clinical-stage biopharmaceutical company headquartered in the UK; 600+ staffwith 3manufacturing sites; R&D operations focused on the development of novel cancer immunotherapy products using affinity-enhanced T-cell receptors.
Joined the senior leadership team of an innovative biotech company and led operations in facilities, engineering, information technology and data science / bioinformatics. Leveraged enterprise perspectives to develop forward-looking strategies, and rapidly scaled functional groups, systems and processes. Lead 60+ staff and managed a $25M annual ops budget. Report to the COO, and serve on Operating Steering Committees reporting to the ELT, Board & Audit Committee.
● Business Maturation & Evolution
• Shared key perspectives with C-suite leaders on the value of technology investments to advance strategic objectives and growth agenda while reducing cost, improving efficiencies and driving product development/ commercialization.
● Introduced a "fit f

Global generics and biopharmaceutical company headquartered in Israel; acquired Cephalon in 2011
Recruited into a rapid-growth, global enterprise as the senior IT leader and business partner to the CEO and executive team of a $6B, 3K+ employee US business with portfolio of 24 small molecule and biologic assets. Given oversight for enterprise IT (infrastructure, shared services, commercial operations, sales/ marketing, compliance and regulatory). Managed 40+ staff and $45M annual budget.
● Business Transformation & Change Management
• Championed multi-year business transformation and change management efforts, including M&As, globalization, organizational restructuring, cost reduction, revenue growth and market expansion.
• Worked through influence to establish trust and confidence with C-suite leaders, introduced an enterprise mindset and business approach by proactively engaging with diverse product groups, business, marketing and sales functions.
• Selected by the CIO to lead M&

Diversified global healthcare corporation with business segments spanning Pharmaceutical, Medical Devices & Consumer Health
Earned successive promotions to become a trusted IT leader and business partner for $9B+ Biotech (Centocor), a J&J acquisition with top-selling immunosuppressive drug, REMICADE®.Given oversight of strategy, operations and key initiatives spanning corporate IT, enterprise systems, shared services, medical/ clinical affairs and compliance, including an 18-member team and $6M annual budget.
● Global Business & Enterprise Transformation
• Shared enterprise perspectives and balanced the needs of stakeholders across 4 lines of business/functional disciplines to digitize, automate and streamline the organization, which optimized headcount and operating expense.
• Played a key role in corporate restructuring and globalization, including centralizing regional operations into global shared service centers, and integrating IT, SAP,medical and compliance functions across

Honed technology innovation and program / project management skills during tenures in the commercial construction, high-tech and logistics / transportation sectors. Key highlights:
• Modernized IT, sales and marketing digital assets as a Program Manager for Pitt Ohio Express.
• Developed a prototype Cloud software platform (precursor to a “Salesforce.com solution”) and partnered with GE as a pilot customer as Development Manager for Information Flow (now defunct).
• Led 200+ people on 4 large construction projects as a Site Manager with Foreman Program & Construction Managers.